News

News

Icon LISA News = LISA News
08.01.2019
Valneva Announces its Intention to Delist from the Vienna Stock
07.01.2019
HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead
07.01.2019
Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate
07.01.2019
Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate
18.12.2018
Curetis’ Subsidiary Ares Genetics Teams Up with Leading
18.12.2018
Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate
18.12.2018
HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus
18.12.2018
AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®
18.12.2018
AddLife acquires Austrian Biomedica – international expansion on 13 new markets
11.12.2018
Small but versatile – Key players in the marine nitrogen cycle can utilize cyanate and urea